Brief: Lepu Biopharma Says Loss For Year Attributable Up 73.8% To RMB1,011 Mln
29/03/2022 13:52
March 29 (Reuters) - Lepu Biopharma Co Ltd 2157.HK :
* LOSS FOR YEAR ATTRIBUTABLE INCREASED 73.8% TO RMB1,011.0
MILLION
* BELIEVES COVID-19 WOULD NOT RESULT IN MATERIAL DISRUPTION
TO
GROUP’S BUSINESS OPERATIONS
Further company coverage: 2157.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lepu Biopharma
See all newsChina's Lepu Biopharma H1 revenue rises 12.1% on higher drug sales
Hong Kong-listed Keymed Biosciences' gastric cancer drug meets late-stage trial goals
Brief: Lepu Biopharma Reports Positive Top-Line Results From Global Phase III Trial Of CMG901 (AZD0901)
Lepu Biopharma set to jump most in 7 months on FY profit forecast
Brief: Lepu Biopharma Expects FY Net Profit Attributable